DxTerity is a genomics company based in Los Angeles that strives to provide a deeper understanding of immune-mediated diseases to improve disease management and treatment. We launched a multi-channel clinical trial enrollment promotion.
The goal of the CHROME clinical study was to help unravel the root biological evidence of disease by focusing on the etiology and pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The study explored the biological basis of ME/CFS by characterizing disease-associated signatures that will help guide the development of better diagnostic testing and treatment.
Samba Scientific was tasked with crafting and executing an effective campaign to register 150-200 ME/CFS patients who would receive instructions to download the monitoring app associated with the trial.
We focused on a multi-channel enrollment promotion and created a lead funnel that utilized bloggers, social media, microsites, and emails. We crafted fresh branding designed to encompass a sense of awakening and balance and built a simple but clear microsite to provide all the necessary information as well as enable easy access to study enrollment: The Chrome Study.
To promote the campaign, we created content to post on top social media platforms (e.g., Facebook and Twitter) to connect with the ME/CFS community using brand-aligned imagery and messaging. We also carefully crafted Google Ads calling for incentivized enrollment and connected with ME/CFS bloggers who promoted a high conversation rate by driving effective awareness of the study.
With a goal of 150-200 registrants, the campaigns produced over 620 total registrants – 335% of our original goal!
Goal
150-200
CFS/ME registrants
Total Registrants
621
Goal
150-200
CFS/ME registrants
Total Registrants
621
Get the latest tips, tricks, and news
Get the latest tips, tricks, and news
Copyright © 2024 Samba Scientific. All rights reserved.